Clinical Trial Update: Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of MRE0094 for chronic, neuropathic diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Foot Ulcer

Drugs mentioned

• MRE0094

Snippet

Sponsor: Pfizer | Conditions: Foot Ulcer, Diabetic, Diabetes Complications | Phase 2 | Status: COMPLETED